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Objectives: To assess the internal consistency and factor structure of the abridged
Spanish version of the Berger HIV Stigma Scale (HSS-21), to provide evidence for its
convergent and discriminant validity, and to describe perceived stigma in an urban
population from northeast Mexico.
Methods: Seventy-five HIV-positive men who have sex with men (MSM) were recruited.
Participants answered the Spanish versions of three Likert-type scales: HSS-21, Rob-
senberg’s self-esteem scale, and the abbreviated version of the Zung’s Depression
Scale.
Results: HSS-21 showed high reliability and validity; its factor structure included four
components: concern with public attitudes; negative self-image; disclosure concerns;
and enacted stigma. The level of stigma was high in 27 out of 75 (36%) participants;
nevertheless, the score found in the component related to disclosure concerns indicated
high level of stigma in 68% of participants. The score of HSS-21 was positively correlated
with the score of depression and negatively correlated with the score of self-esteem.
Conclusion: Results demonstrated high reliability for the HSS-21; correlations with other
scales supported its validity. This scale demonstrated to be a practical tool for assessing
stigma among Mexican HIV-positive MSM. High level of stigma was found only in the
factor related to disclosure concerns.
Policy implications: Identifying HIV-associated stigma through a short, reliable, and
validated instrument will allow the development of interventions that cope and manage
stigma in HIV-positive MSM. HSS-21 distinguishes between different dimensions of
stigma and will contribute to a better understanding of this phenomenon.
Keywords: HIV, AIDS, social stigma, men who have sex with men, public health, validation studies, psychometrics,
Mexico
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Introduction
As the human immunodeficiency virus (HIV) epidemic enters
in its fourth decade, it is still regarded as an important public
health issueworldwide. In turn, the social perception toward those
individuals who live with HIV and AIDS (PLWH) continues to
be a negative one. HIV’s ways of transmission, its implications
regarding the more traditional gender roles, and its association in
the social imaginary to socially marginalized groups are the cause
of stigma and discrimination in various circles (1). Stigma can be
conceptualized as a “mark” (attribute) linking an individual with
a set of undesirable characteristics (stereotypes) (2, 3). Threemain
sub-types of stigma have been described: acted stigma refers to
the actual experience of acts of discrimination. Perceived stigma
refers to the fear experienced by an individual in the presence of
negative attitudes of a society toward a given attribute considered
as undesirable, for example, an ethnic group, a disease, some
personal behaviors, etc. A third sub-type is internalized stigma
(self-stigma), a term which includes the negative beliefs, opinions,
and feelings that an individual holds toward a given attribute and
toward himself/herself as a result of an internalization process of
the societies’ opinions and beliefs toward such attribute (4).
The term HIV- and AIDS-related stigma (HARS) makes refer-
ence to the negative appraisal that society as a whole give to any
person who lives, or is believed to live with HIV and AIDS. In
the psychosocial model developed by Berger et al. (5), the term
“perceived stigma” is conceptualized as the perception of PLWH
of social disqualification (incomplete social acceptance or even
rejection), denial or limitation of opportunities (e.g., housing and
employment offers, access to medical services, etc.), as well as
negative changes to their social identity as a result of their HIV
serostatus. This stigmatization process is also associated to other
factors involved in judgment formation, such as sexual orienta-
tion, diversity of sexual partners, and use of illegal substances. This
“blame the victim” attitude increases the isolation sensation and
the interiorized sense of shame by theHIV infected individual (1).
From a public health perspective, HARS is an important factor
that hinders voluntary testing for a timely diagnosis and treatment
of HIV infection (1, 6, 7). HARS is also an obstacle for individual’s
serodiagnosis disclosure to their sexual partners, thus prolonging
sexual risk behaviors and contributing to HIV transmission (6, 8);
particularly in socially stigmatized and discriminated groups such
as gay men and men who have sex with men (MSM), where social
conditions generated by HARS lead MSM to participate in sexual
risk behaviors with a higher risk of acquisition and propagation
of HIV (9, 10). Thus, it is not a surprise that worldwide gay men
and other MSM are 19 times more likely to be living with HIV
than the general population (11). The incidence of HIV among
MSM is rising in several parts of the world and Mexico is not the
exception (11–13).
Likewise, HARS can also lead PLWH to postpone the use of
medical public health services (6, 14), to a suboptimal adherence
to antiretroviral therapy (15–17), and to a poor overall health
(7, 18). Furthermore, HARS is associated with stress, anxiety,
depressive symptomatology, and a decreased quality of life (19,
20). Aforementioned, HARS and its multiple consequences have
a deep impact on the HIV epidemic development by reinforcing
existing social inequalities with serious implications in public
health policies.
Several instruments have been developed and validated to eval-
uateHARS in PLWH (5, 21–23). One of the best known is theHIV
Stigma Scale (HSS-40) developed byBerger et al. (5). This scale has
been used to assess perceived stigma among adult PLWH (24–27),
likewise it has been adapted for PLWH children (28), and as well
to assess perceived stigma of other diseases (29).
The HSS-40 scale assesses how PLWH feel in regards to four
dimensions of stigma: (a) personalized stigma (or acted stigma),
(b) individuals’ concerns related to disclose his/her own HIV
serostatus, (c) negative self-image (self-stigma), and (d) indi-
viduals’ concerns related to public attitudes toward PLWH. The
instrument has shown evidence of construct validity and high
internal consistency for a set of 40 items (α= 0.96), as well as
for its factors (α= 0.90–0.93) (20). The HSS-40 Spanish language
translation, adaptation, and validation were done by Franke et al.
(30), who also developed a shorter version (HSS-21). Likewise,
as the complete scale version, the HHS-21 also showed evidence
of construct validity (α= 0.84 as a total score), and an adequate-
to-high internal consistency (α= 0.68–0.80) in assessing the four
dimensions of stigma.
Since HARS not only represents one of the greatest obstacles
in preventing new HIV infections but also deeply and negatively
affects multiple aspects of HIV treatment, as well as the physical,
mental, and emotional well-being of the PLWH (31), it becomes
important to assess perceived stigma among PLWH. Considering
the lack of adapted and validated instruments for HARS assess-
ment that could improve current HIV and AIDS public health
policies inMéxico (e.g., Healthy Border 2010/2010 initiative), this
study aims to evaluate the internal consistency, factorial structure,
convergent, and discriminant validity of the HSS-21, as well as to
describe HARS in a sample of HIV-positive MSM in Nuevo León
(Mexican border state with U.S. Texas state).
Materials and Methods
Participants
Research involved 185 MSM and who collaborated with non-
governmental and community-based organizations members
of Nuevo Leon’s Multisectoral STI/HIV/AIDS Response Board
(MEMUREVIH). Inclusion criteria involved only male subjects
who had had sexual experiences with other men, HIV-positive,
aged 18 years or more, and who resided in Nuevo León, Mexi-
can state. Taken into account that most HIV-positive MSM do
not disclose their serological HIV status, this study adopted a
non-probability sampling and a respondent-driven sampling. The
sample consisted of 75 MSM who voluntarily declared to have an
HIV-positive serodiagnosis, and who responded to a written or an
online survey.
Recruitment
The data collection process lasted 60 days. Prior to the data col-
lection process, collaboration was requested to the different non-
governmental and community-based organizations members of
MEMUREVIH to implement the survey in their office location
and to their MSM affiliates. Four properly qualified surveyors
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visited all sites and applied the written or online surveys on
the previously agreed dates and time with the aforementioned
organizations.
Procedure
In order to guarantee information input reliability, a digital survey
database was created and submitted to a double-quality control
check. All subjects were given both verbal and written informa-
tion about the nature of the study, prior to responding to either
the written or online questionnaire. The study procedures were
undertaken according to ethical principleswith the understanding
and written consent of each subject. The study protocol was
reviewed and approved by the ethics and research committee at the
Tecnologico de Monterrey. Anonymity was guaranteed through-
out the process, as well as confidentiality of both physical and
electronic data. To access the online questionnaire, respondents
accessed the survey via the website – (www.encuestas.no-ip.org),
and none of the log-in data (IP address, etc.) was stored in the elec-
tronic access. Completion of either the written or online survey
took an average of 25min.
Instrument
The study used an analytical-type structured questionnaire
(closed-ended questions and multiple response alternatives) in
either written or online formats. The questionnaire explored
socio-demographic characteristics, perception of HARS, self-
esteem, and depression by means of the following Likert-type
scales:
HIV Stigma Scale (HSS-21)
The abridged and Spanish-adapted version of the HIV stigma
scale (HSS-21) used in this study was developed by Franke et al.
(29); it is composed of 21 positively keyed items that are evaluated
along a 4-point Likert-type scale (from 1= strongly disagree to
7= strongly agree), and was shown to be internally consistent.
The sum of these items yields a total score, with higher scores
representing a greater degree of perception of stigma.
Rosenberg Self-Esteem Scale (RSS-10)
It is composed of 10 items rated on a 4-point Likert-type scale.
Possible scores range from 10 to 40, with higher ones indicating
greater self-esteem.Amongmen, scores lower than 28 indicate low
self-esteem (32).
Zung Depression Scale (ZDS-10)
Zung depression scale constituted of 20 items that involve affec-
tive, psychological, and somatic symptoms. Respondents indi-
cate the frequency with which any symptom is experienced: the
higher the score, the greater the degree of depressive symptoms.
Diaz et al. (33) developed and validated a short, Spanish-adapted
version of this scale (ZDS-10); the cut-off point to distinguish
the presence of clinically significant depressive symptoms is 22
(sensitivity= 92.3%, specificity= 71.4%).
Statistical Analysis
Two psychometric properties of the items in HSS-21 were esti-
mated: discrimination and internal consistency. Discrimination
was estimated by the ability to differentiate in a statistically
significant manner the high score group (percentile equal or
>73) and the low score group (percentile equal or <27) in the
sum score of the 21 items. A mean difference higher than two
was considered to be significant, as well as a reliable discrimi-
nant property for each one of the assessed items. The internal
consistency of the items was estimated by means of: corrected
correlation, estimation of Cronbach’s alpha excluding the item,
and communalities. It was sought that the corrected correla-
tion values were >0.30, that a non-decrease value of Cronbach’s
coefficient alpha after eliminating the item could demonstrated
a reliable internal consistency, and that the communalities val-
ues were >0.20. Consistency was interpreted as high when it
expressed a value equal or >0.70. The distribution fitting to a
normal curve was contrasted using Kolmogorov–Smirnov test
or Shapiro–Wilk test (34). All data were analyzed with SPSS®
software (version 20.0).
The dimensional structure was studied bymeans of exploratory
factor analysis; considering appropriate factoring characteristics:
(a) that the determinant of the correlation matrix would tend to
0 (|R|< 0.01), (b) KMO> 0.6, and (c) that the null hypothesis
of equivalence of the correlation matrix to an identity matrix by
Bartlett’s sphericity test would be rejected (34). The extraction
was executed by generalized least squares (GLS) and the Pro-
max rotation method of the factor matrix, adjusting the solution
to four factors in agreement with the structure found in other
studies (5, 30).
The correlations between factors were calculated by Pear-
son’s correlation coefficient. The correlations between the HSS-21
scores and the EDZ-10 and RSS-10 scores were established by
Spearman’s rho. The significance of the score difference in the
scales ZDS-10 and RSS-10 among the respondents who expressed
or did not expressedHARSwas carried out by theMann–Whitney
U test. The effect size was calculated by Cohen’s d (34).
Results
Respondents
The 75 HIV-positive MSM respondents had an average age of 35
(SD= 7.38) years old. Median time since HIV infection diagnosis
was 18months. Average years in school was 13.93 (SD= 3.73)
years. At the time of the survey 81.9% of men were working full
time, while 10.6% worked part time, and 7.4% were unemployed.
Moreover, despite of employment status, 69.2% indicated that
they received amonthly income of15,000MXN ($ 1.146/867.45
AC). Regarding sexual orientation, 88% of participants defined
themselves as homosexual, 9.23% as bisexual, and 2.67% as het-
erosexual.
HSS-21 Descriptive Statistics
The HSS-21 mean total score was 76.28 (SD= 21.522) and its
distribution was fitted to a normal curve (ZK-S= 0.67, p= 0.20).
Considering the whole scale items, its mean can be transformed
into a continued value between 1 and 7 or equal to 3.63. Using the
same procedure, most items means scores were also between 2.5
and 4. However, eight items (V2, V6, V11, V12, V14, V15, and
V17) had a mean value4 (Table 1).
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TABLE 1 | HSS-21 items’ descriptive statistics, interpretation, homoscedasticity, discrimination, and internal consistency.
Item Descriptive statistics K–S I Homoscedasticity Discrimination Consistency
M Mdn Mo SD Sk K Z p F p MD t df p ri, t i αt i hi
V1 2.95 3 1 2.18 0:63  1:03 0.29 0.00 2 1:67 0.20 2.7  4:75 38 0.00 0.48 0.88 0.62
V2 4.73 5 5 1.84  0:69  0:17 0.30 0.00 3 18:10 0.00 2.5  4:54 26:66 0.00 0.52 0.87 0.70
V3 3.85 3 3 2.23 0:16  1:33 0.21 0.00 2 0:79 0.38 2.6  3:86 38:00 0.00 0.38 0.88 0.70
V4 2.73 3 1 1.95 0:81  0:47 0.28 0.00 2 2:10 0.15 2.2  4:41 38:00 0.00 0.36 0.88 0.44
V5 3.21 3 1a 1.96 0:14  1:36 0.25 0.00 2 0:05 0.82 2.4  4:22 38:00 0.00 0.43 0.88 0.56
V6 4.07 5 5 1.65  0:55  0:39 0.33 0.00 3 3:63 0.06 2.6  5:81 38:00 0.00 0.55 0.87 0.74
V7 2.52 1 1 1.83 0:83  0:50 0.32 0.00 2 9:62 0.00 2.6  5:64 30:76 0.00 0.56 0.87 0.71
V8 2.20 1 1 1.68 1:16 0:28 0.36 0.00 1 12:10 0.00 2.5  5:54 29:67 0.00 0.55 0.87 0.62
V9 3.53 3 5 1.72  0:16  9:98 0.26 0.00 2 0:21 0.65 2.3  5:04 38:00 0.00 0.40 0.88 0.64
V10 1.99 1 1 1.48 1:35 0:97 0.39 0.00 1 20:14 0.00 2.3  5:68 23:89 0.00 0.56 0.87 0.68
V11 4.44 5 5 1.70  0:52  0:16 0.31 0.00 3 8:37 0.00 2.5  5:15 32:44 0.00 0.55 0.87 0.73
V12 6.31 7 7 1.21  1:94 4:45 0.42 0.00 4 3:35 0.07 0.5  1:12 38:00 0.27 0.06 0.88 0.65
V13 3.00 3 1 2.00 0:67  0:23 0.23 0.00 2 15:31 0.00 2.5  4:86 26:32 0.00 0.41 0.88 0.60
V14 4.44 5 5 1.56  0:50 0:55 0.32 0.00 3 0:02 0.90 2.7  6:76 38:00 0.00 0.58 0.87 0.59
V15 4.23 5 7 2.39  0:28  1:48 0.21 0.00 3 9:30 0.00 4.4  8:63 25:59 0.00 0.68 0.87 0.76
V16 2.16 5 5a 2.16 0:33  1:12 0.21 0.00 1 6:81 0.01 2.7  4:34 32:67 0.00 0.44 0.88 0.64
V17 4.84 5 7 2.13  0:53  0:99 0.23 0.00 3 6:73 0.01 3.3  5:96 28:57 0.00 0.63 0.87 0.67
V18 3.87 3 3 2.07 0:44  0:95 0.23 0.00 2 8:25 0.00 2.2  3:47 31:76 0.00 0.32 0.88 0.77
V19 2.97 3 3 1.72 0:55  0:36 0.24 0.00 2 2:25 0.14 2.1  4:58 38:00 0.00 0.38 0.88 0.74
V20 3.37 3 1 2.02 0:26  1:10 0.20 0.00 2 6:75 0.01 2.9  5:22 29:50 0.00 0.53 0.87 0.62
V21 3.03 3 3 1.82 0:64  0:30 0.25 0.00 2 9:76 0.00 3.1  6:94 27:84 0.00 0.64 0.87 0.73
M, mean; Mdn, median; Mo, mode; SD, standard deviation; Sk, skewness; K, kurtosis; K–S, Kolmogorov–Smirnov test; p, probability; I, interpretation; 1, totally in disagreement; 2, in
disagreement; 3, in agreement; 4, totally in agreement; MD, mean difference between the group with high scores and the group with low scores in the scale; df, degrees of freedom;
ri,t-i, correlation between the item and the scale; αt i, Cronbach’s alpha coefficient after removing the item; hi, communality.
a
αt i, Cronbach’s alpha coefficient after removing the item (significance α0.70).
Discrimination, Internal Consistency, and Validity
of HSS-21 Items
HSS-21 presented a high internal consistency (α= 0.88). Items
expressed reliable internal consistency values, since deletion of
none of them increased Cronbach’s alpha coefficient. Items’ cor-
rected correlations ranged from 0.32 to 0.68 (except item V12,
whose corrected correlation was 0.06). Initial communalities var-
ied between 0.44 and 0.77, except for item V12 (MD= 0.05).
Thus, with the exception of item V12, the remaining 20 items had
reliable psychometric properties (Table 1).
HSS-21 Dimensional Structure
The correlationmatrix of the 21 items of the HSS-21 scale showed
adequate properties for factor extraction. Its determinant tended
to 0 (|R|< 0.01), the KMO index was >0.6 (KMO= 0.777), and
the null hypothesis of equivalence of the correlation matrix to an
identity matrix by Bartlett’s sphericity test was rejected [χ2 (210,
N = 75)= 752.413, p< 0.001]. Four components were extracted,
which accounted for 60.51% of the total variance.
After rotating the factor component matrix by the Promax
method and performing the extraction by GLS, four factors were
found with a high internal consistency; they were constituted
by positive indicators and factor loadings >0.32 (Table 2). The
first factor (self-stigma, VNS) integrated by six items (V1, V4,
V7, V8, V10, and V16) related to feelings of not being as good
as others and emotion of guilt or shame (α= 0.81). The second
factor (acted stigma, VES) integrated by five items (items V13,
V18, V19, V20, and V21) related to the consequences of others
finding out the individuals’ serodiagnosis and personal experi-
ences of rejection (α= 0.83). The third factor (concern about
public attitude toward HIV and AIDS, VPA) integrated by five
items (V5, V6, V9, V11, and V14) related to what PLWH believe
that other people could think of them if they knew their serosta-
tus (α= 0.83). The fourth factor (PLWH concern about HIV
serodiagnosis disclosure, VDC) integrated by five items (V2, V3,
V12, V15, and V17) related to the perceived need of controlling
HIV serodiagnosis information (α= 0.76). Item 21 had a high
factor loading in two factors. Nevertheless, including it in the
second factor increased its internal consistency from 0.80 to 0.83,
due to its content item 21 is highly related to acted stigma. The
correlations between factors were medium (r= 0.32–0.46), with
the exception of the correlation between factors 3 and 4, which
was small (r= 0.21).
HSS-21 Factors’ Descriptive Statistics
The score range for all items is from 1 to 7 and the higher score
results are correlated to a high stigma. Considering the number of
items in each of the four factors, their mean can be transformed
into a continuous value within 1 and 7. Such value can be inter-
preted as the answer label for each item, dividing the answer range
value by four intervals of constant amplitude. Table 3 exposes
factor descriptive statistics.
The mean of VNS can be interpreted as a non-definitive dis-
agreement with HARS dimension. Means comparison among
the 36 (48%) respondents who expressed stigma [M= 5.04,
SD= 0.59; 95% IC= (4.85, 5.24)] and the 39 (52%) respondents
who did not express stigma [M= 3.02, SD= 0.74; 95% IC= (2.78,
3.26)] were statistically significant (p< 0.01).
Also, VESmean can be interpreted as a non-definitive disagree-
ment with HARS dimension. The comparison of means among
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TABLE 2 | HSS-21 factors’ loadings from exploratory factor analysis.
Item Factor
1 2 3 4
V6 Most people believe a person who
has HIV is dirty
0.88
V11 Most with HIV are rejected when
others learn I have HIV
0.77
V9 Most people think a person with HIV
is disgusting
0.73
V5 People with HIV are treated like
despicable persons
0.71
V14 Most people are uncomfortable
around someone with HIV
0.59
V21 People seem afraid of me because I
have HIV
0.53 0.44
V7 Having HIV makes me feel unclean 0:93
V8 I feel set apart, isolated from the rest
of the world
0:71
V10 Having HIV makes me feel I am a
bad person
0:68
V1 I feel guilty because I have HIV 0:67
V4 I feel I am not as good as others
because I have HIV
0:36
V16 Having HIV in my body is disgusting
to me
0:32
V2 Telling someone I have HIV is risky 0.77
V15 I worry that people may judge me
when they learn I have HIV
0.76
V17 I worry people who know I have HIV
will tell others
0.69
V3 I work hard to keep my HIV a secret 0.65
V12 I am very careful whom I tell that I
have HIV
 0:39 0.50
V18 I regret having told some people that
I have HIV
0.93
V19 As a rule, telling others has been a
mistake
0.92
V20 Some people act as though it is my
fault I have HIV
0.51
V13 Some people who know have grown
more distant
0.37 0.48
Extraction method: GSL. Rotation method: Promax with Kaiser normalization.
the 23 (30.7%) respondents who expressed stigma [M= 4.96,
DE= 0.69; 95% IC= (4.66, 5.26)] and the 52 (69.3%) respondents
who did not express stigma [M= 2.34, SD= 0.91; 95% IC= (2.09,
2.60)] was statistically significant (p< 0.01).
The VPAmean can be interpreted as a non-definitive disagree-
ment with HARS dimension. The comparison of means among
the 40 (53.3%) respondents who expressed stigma [M= 4.99,
DE= 0.65; 95% IC= (4.78, 5.20)] and the 35 (36.7%) respondents
who did not express stigma [M= 2.74, SD= 0.75; 95% IC= (2.48,
3.00)] was statistically significant (p< 0.01).
Likewise, VDC mean can be interpreted as a non-definitive
disagreement with HARS dimension. Means comparison among
the 51 (68%) respondents who expressed stigma [M= 5.59,
DE= 0.94; 95% IC= (5.32, 5.85)] and the 24 (32%) respondents
who did not express stigma [M= 3.10, SD= 0.74; 95% IC= (2.79,
3.41)] were statistically significant (p< 0.01).
ZDS-10 Descriptive Statistics
ZDS-10 scale had an average score of 20.48 (SD= 4.82) with
a non-normal distribution curve (ZK-S= 0.11, p= 0.02). Like-
wise, scores among the 48 respondents who did not express
stigma showed a non-normal distribution curve (ZS-W= 0.93,
p= 0.01). Whereas, distribution among the 27 respondents who
expressed stigma was adjusted to a normal curve (ZS-W= 0.95,
p= 0.17).
After running the Mann–Whitney U test, it was found that the
respondents with HARS had significantly higher scores in ZDS-
10 [M= 22.41, SD= 4.40, n= 27; 95% IC (20.67, 24.15)] than the
scores of the respondents without HARS [M= 19.40, SD= 4.74,
n= 48; 95% IC (18.02, 20.77)], with amedium size effect of stigma
on the total ZDS-10 score; Z= 2.37, p< 0.02, d= 0.65, 95% IC
(0.16, 1.13).
Of the 48 HIV-positive MSM respondents who did not express
HARS, 14 (29.17%) presented clinically significant symptoms of
depression, while 34 (70.83%) did not show such symptoms. Of
the 27 respondents who expressed HARS, 16 (59.26%) showed
clinically significant symptoms of depression, while 11 (40.74%)
did not showed such symptoms.
RSS-10 Descriptive Statistics
The mean in the total score of the RSS-10 was 34.43 (SD= 4.78)
with a non-normal distribution curve (ZK-S= 0.20, p< 0.0.001).
Similarly, the distribution of the scores between the respondents
who did not express stigma (ZS-W= 0.87, p= 0.001) and those
who did express stigma (ZS-W= 0.88, p= 0.007) presented a
non-normal distribution curve.
After running the Mann–Whitney U test, it was found that the
HIV-positive MSM respondents who did not express HARS had
significantly higher RSS-10 scores [M= 35.53, SD= 3.62, 95% IC
(34.50, 36.60)] than those of the respondents who did express
HARS [M= 32.48, SD= 5.93, 95% IC (30.14, 34.83)], with a
medium size effect of stigma on the total RSS-10 score; Z= 2.26,
p< 0.03, d= 0–67, 95% IC ( 1.14, 0.18).
Of the 48 respondents who did not express HARS, one (2%)
respondent presented a low self-esteem and 47 (98%) presented a
high self-esteem. Of the 27 respondents who expresses HARS, six
(22.2%) respondents presented a low self-esteem and 16 (77.8%)
presented a high self-esteem.
Validity Evidences
The total HSS-21 score expressed convergent validity with a sig-
nificant and direct correlation to the ZDS-10 total score. The
factors that expressed a high correlation were VNS (ρ= 0.336,
p< 0.001) and VES (ρ= 0.252, p< 0.01). Also, the total HSS-
21 score demonstrated discriminant validity with significant
and reverse correlation to RSS-10 total score. HSS-21 factors
showed correlations from small (VNS, VDC, and VES) to triv-
ial (VPA) with the RSS-10, but did not reached a statistical
significance.
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TABLE 3 | HSS-21 factors’ descriptive statistics.
Factor Descriptive statistics K–S Interpretation
M Mdn Mo SD Sk K Z p
VNS 3.99 3:83 3:83 1.22  0:17  0:66 0.10 0.07 In disagreement
VES 3.15 3 1 1.48 0:56  0:40 0.10 0.07 In disagreement
VPA 3.94 4:2 5 1.33  0:22  0:71 0.18 0.01 In disagreement
VDC 4.79 4:6 4:6 1.46 0:81  0:47 0.10 0.07 In agreement
M, mean; Mdn, median; Mo, Mode; SD, standard deviation; Sk, skewness; K, kurtosis; K–S, Kolmogorov–Smirnov test; p, probability; VNS, negative self-image; VES, enacted stigma;
VPA, public attitude; VDC, disclosure concerns.
Discussion
Stigma can be conceptualized as a deeply degrading attribute
that binds an individual with one or more undesirable charac-
teristics and finally diminish socially his/her self-image. Concern
about stigma is widely extended among PLWH, although this is
not universal (35). The results of the study determined that the
Spanish-adapted version of the HSS-21 scale developed by Franke
et al. (30) has good overall internal consistency, reliability, and
psychometric characteristics among the sub-population studied
(HIV-positive MSM).
From the HSS-21 total scores, more than half (64%) of the
HIV-positive MSM respondents did not express HARS. However,
VDC factor scores showed that 68% of the respondents perceived
HARS. The HSS-21 score had a significant and direct correlation
with the ZDS-10 total score, showing evidence of convergent
validity. Likewise, it also presented a significant and reverse
correlation with the RSS-10 total score, demonstrating evidence
of discriminant validity. The respondents who perceiveHARS had
significantly higher scores (p< 0.02) in ZDS-10 and significantly
lower scores (p< 0.03) in RSS-10 than the respondents who do
no perceive HARS.
There are only a small number of published studies on inter-
ventions and programs designed to reduce HARS. Given the diffi-
culties in defining and measuring stigma, few such interventions
and programs described in the literature have been rigorously
evaluated in developing countries (10, 21). One of the limitations
of this study – typically found in other HIV-related studies –
is the fact that it was conducted with a small and convenience
sample. For this reason, the study does not offer sufficient data
to assess the true meaning of the stigma scores of the scale,
and herein reported results and derived conclusions should be
considered as hypothetical for similar social groups, which limits
the ability to apply it to the general PLWH population, or to
draw conclusions about the impact of perceptions of HARS in
Mexico. Moreover, HARS data were obtained through a self-
reported evaluation and therefore they can be different from those
obtained through an interview, projective tests, or psychophysio-
logical tests, etc. Also, sexual orientation, gender identity, social,
economic, and cultural differences need to be assessed. Neverthe-
less, the findings can serve as the basis for HARS measurement
research with Spanish-speaking populations in Mexico and other
countries.
To improve our understanding of HARS, it is necessary to focus
on a series of distinguishable variables across different societies.
Implementing HARS evaluation in PLWH is important, as it
can lead to identify clinically significant symptoms of depression
which could have a negative influence in treatment adherence
(15–17), it could also limit the use of public health services (36,
37) and limit social support seeking due to fear of rejection (38,
39). Identifying perceived stigma among PLWH through a short,
reliable, and validated instrument provides data that will help
governments make efficient and effective use of resources spent
on stigma and discrimination reduction as well as the opportu-
nity to develop public health interventions that help PLWH to
cope and manage stigma. The implementation and evaluation
of these strategies will benefit from the availability of a widely
validated and user-friendly psychometric instruments to assess
the HARS.
This study was the first to use the Spanish-adapted version of
the HSS-21 scale in HIV-positive MSM in Mexico, and the find-
ings help move from evaluating HARS to implementing reduc-
tion interventions to mitigate the impact of HARS and promote
empowerment among HIV-positive men and to enhance the sex-
ual health of gay and bisexual men through a community-based
process involving the MEMUREVIH (program developed by a
consortium of members who represent four sectors: academia,
government, key population, non-governmental and community-
based organizations in Nuevo León state). Through study results,
the MEMUREVIH intervention aimed to diminish HARS, create
greater support for HIV-positive men, make disclosure safer and
easier, discourage reliance on disclosure to prevent HIV trans-
mission and encourage testing. The contact hypothesis suggests
that facilitating social interaction between PLWH and others (e.g.,
healthcare providers, friends, family, co-workers, etc.) may help to
reduce prejudice, stereotypes, and discrimination among others
via the mechanisms of increased knowledge of HIV, reduced
social anxiety regarding PLWH, and increased empathy toward
PLWH (40). The corresponding author is currently working on
MEMUREVIH intervention data.
As HARS places people at a substantial social disadvantage, it
increases their exposure to risks and limits access to protective
factors, potentially adding to their burden of disease or disability.
Stigma not only predisposes PLWH to greater HARS and dis-
crimination but also critically reinforces stereotyping and status
loss of all them, regardless of how they may have acquired the
infection. In such manner, underestimating the insidious power
of stigma jeopardizes the success of public health programs aimed
to prevent, timely detect, and treat HIV and AIDS. HSS-21 scale
distinguishes different dimensions of stigma and contributes to
better understand HARS impact in public health-related issues.
Furthermore, the intention is also to encourage researchers to
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consider additional ways to reduce stigma and discrimination,
acknowledging and addressing HARS challenges with research
methodology; thereby, creating a sense of timeliness and urgency
for the development and testing of HARS, and thus, contributing
with discrimination reduction efforts. It is only with stronger,
more nuanced understandings of HARS that we will be able to
break the associations betweenHIV stigma and indicators of poor
affective, behavioral, and physical health and well-being among
PLWH within interventions.
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